Z. Zhu

发表

Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon.

R. Kuick, S. Hanash, D. Beer, 2000, Cancer research.

Apoptosis induced by 5-flucytosine in human pancreatic cancer cells genetically modified to express cytosine deaminase.

Z. Zhu, S. Yuan, S. Zhang, 2000, Acta pharmacologica Sinica.

In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention.

H. Ganther, Zongjian Zhu, H. Thompson, 2000, Cancer research.

Toward the production of bispecific antibody fragments for clinical applications.

P. Carter, J. Ridgway, Z. Zhu, 1995, Journal of hematotherapy.

Morphological and biochemical status of the mammary gland as influenced by conjugated linoleic acid: implication for a reduction in mammary cancer risk.

H. Thompson, Z. Zhu, C. Ip, 1997, Cancer research.

Chemoprevention of mammary cancer with Se-allylselenocysteine and other selenoamino acids in the rat.

H. Ganther, Zongjian Zhu, H. Thompson, 1999, Anticancer research.

Molecular mechanisms associated with Se-allylselenocysteine regulation of cell proliferation and apoptosis.

H. Ganther, H. Thompson, W. Jiang, 2001, Cancer letters.

Inhibition of human B‐cell chronic lymphocytic leukemia by a monoclonal antibody in xenograft models

Zhen-ping Zhu, D. Hoskin, Z. Zhu, 1994, International journal of cancer.

CIP2A silencing alleviates doxorubicin resistance in MCF7/ADR cells through activating PP2A and autophagy

Z. Zhu, Z. Wei, 2021, Clinical and Translational Oncology.

Acquired antagonistic activity of a bispecific diabody directed against two different epitopes on vascular endothelial growth factor receptor 2.

P. Bohlen, K. Persaud, Z. Zhu, 1999, Journal of immunological methods.

Identification of heavy chain residues in a humanized anti-CD3 antibody important for efficient antigen binding and T cell activation.

P. Carter, Z. Zhu, 1995, Journal of immunology.

Tumor localization and therapeutic potential of an antitumor-anti-CD3 heteroconjugate antibody in human renal cell carcinoma xenograft models.

Z. Zhu, S. Lee, D. McKean, 1994, Cancer letters.

Glargine Promotes Human Colorectal Cancer Cell Proliferation via Upregulation of miR-95

Z. Zhu, J. Qin, J-A Teng, 2015, Hormone and Metabolic Research.

Apoptosis induction by a novel anti-prostate cancer compound, BMD188 (a fatty acid-containing hydroxamic acid), requires the mitochondrial respiratory chain.

S. Wahl, B. Taffe, L. Li, 1999, Cancer research.

Epstein-Barr virus transformed human B-cell chronic lymphocytic leuke

D. Hoskin, Z. Zhu, S. Lee, 2006 .

Immunoreactivity, stability, pharmacokinetics and biodistribution of a monoclonal antibody to human leukemic B cells after three different methods of radioiodination.

Z. Zhu, C. Yang, T. Ghose, 1994, Nuclear medicine and biology.

Pharmacokinetics, biodistribution and tumor localization of two anti-human B-cell chronic lymphocytic leukemia monoclonal antibodies and their F(ab)'2 fragments in a xenograft model.

Z. Zhu, S. Lee, C. Yang, 1994, Cancer letters.

Cell-based selection of internalizing fully human antagonistic antibodies directed against FLT3 for suppression of leukemia cell growth

D. Ludwig, H. Li, Z. Zhu, 2005, Leukemia.

Apoptosis in the absence of cytochrome c accumulation in the cytosol.

L. Li, Z. Zhu, D. Tang, 1998, Biochemical and biophysical research communications.

miR-367 promotes epithelial-to-mesenchymal transition and invasion of pancreatic ductal adenocarcinoma cells by targeting the Smad7-TGF-β signalling pathway

Z. Zhu, Q. Liu, Peng Wang, 2015, British Journal of Cancer.

Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis

A. F. Castro, R. Pincheira, Z. Zhu, 2010, Oncogene.

Expression profiles analysis of pancreatic cancer.

Z. Zhu, C. Wang, P. Shen, 2013, European review for medical and pharmacological sciences.

Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.

D. Hicklin, P. Bohlen, Z. Zhu, 1998, Cancer research.

Efficient inhibition of multidrug-resistant human tumors with a recombinant bispecific anti-P-glycoprotein × anti-CD3 diabody

Z. Zhu, Y. Xu, L. Qin, 2004, Leukemia.

Impact of antibody framework residue VH-71 on the stability of a humanised anti-MUC1 scFv and derived immunoenzyme

D. Newton, S. Rybak, X. Ji, 2004, British Journal of Cancer.

Upregulation of Fas and FasL expression in testosterone-induced apoptosis of macrophages.

Z. Zhu, H. Zhang, D. Guo, 2003, Methods and findings in experimental and clinical pharmacology.

A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. I: In vitro studies.

Z. Zhu, A. Porter, D. Tang, 1999, Anticancer research.

Rheb activates AMPK and reduces p27Kip1 levels in Tsc2-null cells via mTORC1-independent mechanisms: implications for cell proliferation and tumorigenesis

A. F. Castro, R. Pincheira, Z. Zhu, 2010, Oncogene.

A novel hydroxamic acid compound, BMD188, demonstrates anti-prostate cancer effects by inducing apoptosis. II: In vivo efficacy and pharmacokinetic studies.

L. Marnett, Z. Zhu, K. Honn, 1999, Anticancer Research.